HomeQURE • NASDAQ
add
Uniqure NV
Nakaraang pagsara
$17.78
Sakop ng araw
$17.35 - $18.20
Sakop ng taon
$8.73 - $71.50
Market cap
1.10B USD
Average na Volume
1.92M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 5.57M | 6.65% |
Gastos sa pagpapatakbo | 15.55M | 306.77% |
Net na kita | -37.09M | 49.38% |
Net profit margin | -666.06 | 52.53% |
Kita sa bawat share | — | — |
EBITDA | -47.19M | -26.81% |
Aktuwal na % ng binabayarang buwis | 9.55% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 622.54M | 69.39% |
Kabuuang asset | 824.91M | 48.22% |
Kabuuang sagutin | 626.01M | 11.13% |
Kabuuang equity | 198.90M | — |
Natitirang share | 62.53M | — |
Presyo para makapag-book | 5.57 | — |
Return on assets | -14.64% | — |
Return on capital | -16.77% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -37.09M | 49.38% |
Cash mula sa mga operasyon | -77.57M | -46.79% |
Cash mula sa pag-invest | -441.37M | -1,557.79% |
Cash mula sa financing | 2.45M | 137.58% |
Net change in cash | -516.75M | -457.14% |
Malayang cash flow | -82.10M | -62.23% |
Tungkol
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies. Wikipedia
CEO
Itinatag
1998
Website
Mga Empleyado
221
